Cargando…
The effect of apatinib in the treatment of metastatic renal cell carcinoma: a case report and review of the literature
The aim of this study was to explore the effect of apatinib in the treatment of metastatic renal cell carcinoma (mRCC) and related adverse events. A case of mRCC was reported which recurred after surgery and roferon treatment. The patient was treated with apatinib at a dose of 500 mg orally, twice d...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503666/ https://www.ncbi.nlm.nih.gov/pubmed/28740436 http://dx.doi.org/10.2147/IMCRJ.S137484 |